Your shopping cart is currently empty

MK-8318 is an effective and selective antagonist of the CRTh2 receptor (Ki: 5.0 nM).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $2,120 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $2,780 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $3,700 | 10-14 weeks | 10-14 weeks |
| Description | MK-8318 is an effective and selective antagonist of the CRTh2 receptor (Ki: 5.0 nM). |
| Targets&IC50 | CRTH2/DP2 receptor:5.0 nM (ki), β-arrestin:3.5 nM, CYP2C9:50 μM, cAMP:8.0 nM, CYP2D6:50 μM, CYP3A4:50 μM |
| In vitro | MK-8318 suppresses β-arrestin, cAMP, CYP3A4, CYP2C9, and CYP2D6 (IC50s: 3.5±2.1 nM, 8.0±6.8 nM, 50 μM, 50 μM and 50 μM). |
| In vivo | MK-8318 demonstrates 76% efficacy in late airway response (LAR) and 114% efficacy in airway hyperresponsiveness (AHR) by blocking LAR and AHR after intravenous infusion at 1 mg/kg in a sheep model. It also exhibits good efficacy on BAL cells/pulmonary function in ovalbumin-sensitized and -challenged Brown Norway rats at 3, 10, and 30 mg/kg oral dosing. |
| Molecular Weight | 534.5 |
| Formula | C27H26F4N2O5 |
| Cas No. | 1416581-40-2 |
| Smiles | N(C(CCC(O)=O)=O)([C@H]1C=2C(N(C(=O)C3=CC=C(OC(F)(F)F)C=C3)[C@@]4([C@]1(CCC4)[H])[H])=CC=C(F)C2)C5CC5 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.